Our findings expand the spectrum of proteinopathy in ALS to include mitochondrial scaffold protein aggregation, offering new insights into disease pathogenesis and highlighting potential therapeutic targets. The gene discussed is PROS1; the disease is amyotrophic lateral sclerosis.